Jeffrey r. Nesheim, PharmD, MS

Medical Science Liaison Director
Urovant Sciences
littleton, Colorado, United States

Presentation(s):

• Real-World Adherence and Persistence of Vibegron Versus Oral Overactive Bladder Treatments

  Thursday, October 5, 2023
  4:16 PM – 4:20 PM US PST

  Disclosure(s): Urovant: Employee (Ongoing)